READ-IT

  • Learning and Monitoring Zone

Search

  • Home
  • About READ-It
    • READ-It Partners
    • Key achievements
    • READ-It Management Office
  • Publications & Multimedia
    • READ-It annual reports
    • Resources
    • Guidelines
    • Multimedia resources
    • Other publications and stories
  • Cochrane reviews
    • Cochrane Reviews: COVID-19
    • Cochrane Reviews: Other topics
    • Cochrane Reviews: Maternal and child health
    • Cochrane Reviews: Neglected tropical diseases
    • Cochrane Reviews: HIV/AIDS
    • Cochrane Reviews: Tuberculosis
    • Cochrane Reviews: Diarrhoea
    • Cochrane Reviews: Malaria
  • News & Events

Cochrane Reviews on COVID-19 by the READ-It team

Cochrane Reviews on Malaria by the READ-It team

Cochrane Reviews on neglected tropical diseases by the READ-It team

Cochrane Reviews on tuberculosis by the READ-It team

Cochrane Reviews on maternal and child health by the READ-It team

Cochrane Reviews on HIV/AIDS by the READ-It team

Cochrane Reviews on Diarrhoea by the READ-IT team

The Research, Evidence and Development Initiative (READ-It) is an accountable grant funded by UK aid through the Foreign, Commonwealth and Development Office (FCDO) (project number 300342-104) and runs from 2018 to 2024. READ-It builds upon the previous work of the UK aid-funded Effective Health Care Research Consortium (EHCRC) (grant number 5242). Visit the archived EHCRC website to find out more about EHCRC’s work from 2009-2018.

High-quality systematic reviews are key to informing FCDO policies and health-related sustainable development goals, and are exactly what READ-It will produce. These systematic reviews are carefully conducted assessments of the reliable research evidence, and are sifted, appraised, and summarized. Each review has a specific research question, often related to the effects of an intervention or policy for the health of poor people. This new initiative will allow READ-It to identify topics, assemble multidisciplinary review teams, produce and quality assure the reviews, disseminate the findings, and update the reviews as new evidence emerges.

0

What we do

About READ-It

Over the past 20 years there has been a concerted effort to use reliable evidence in making decisions about health care. READ-It aims to improve the evidence base and ensure its dissemination. 

READ-It Partners

The READ-It Partners have significant experience engaging in national and international policy debate and awareness-raising activities in their areas of expertise.

Key achievements

Cochrane Infectious Diseases Group, UK

Cochrane Thematic Group on Person-Centred Care, Health Systems and Public Health (successor Cochrane entity to EPOC)

South African Partners

EPPI Centre, UCL Institute of Education, UK

Christian Medical College Vellore, India

The Union, South East Asia - Partner in Years 1-3 (April 2019 - March 2022)

Birat Nepal Medical Trust - Partner in Years 2-3 (June 2020 -March 2022)

University of Zambia - Partner in Years 1-2 (April 2019-March 2021)

Campbell South Asia - Partner in Year 1 (April 2019-March 2020)

1

Latest Publications

30 Nov 2023

Update: Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19

The combination of nirmatrelvir with ritonavir (Paxlovid®) is a new medicine developed to treat infection with the SARS‐CoV‐2 virus and aims to avoid severe COVID‐19 in people without symptoms, or those with mild symptoms. This review update assesses the efficacy and safety of nirmatrelvir/ritonavir plus standard of care (SoC) compared to SoC with or without placebo, or any other intervention for treating COVID-19 or preventing SARS-CoV-2 infection.
Cochrane Systematic Review: UPDATE
16 Oct 2023

Updated: WHO Guidelines for malaria

The latest version of the WHO Guidelines for malaria was updated in October 2023. These Guidelines supersede 2 previous WHO publications: the Guidelines for the treatment of malaria, third edition and the Guidelines for malaria vector control.
Dissemination products
12 Oct 2023

The impact of growth monitoring and promotion on health indicators in children under five years of age in low‐ and middle‐income countries

There is limited and uncertain evidence on the effectiveness of growth monitoring and promotion on key child health indicators state the authors of this Cochrane review Note: this Cochrane Review supersedes the published Cochrane Review Panpanich 1999.
Cochrane Systematic Review: NEW
View all resources
1

News

Latest publications for November 2023 from Cochrane Infectious Diseases Group

What's New! CIDG publications November 2023
30 Nov 2023

Latest publications for October 2023 from Cochrane Infectious Diseases Group

What's New! CIDG publications October 2023
31 Oct 2023

READ-It update on publications: July - September 2023

READ-It update on publications: July - September 2023
12 Oct 2023

Events

10
Sep

Global Evidence Summit 2024

The GES 2024 programme will aim to promote shared learning and collaboration across all partner organisations and Summit participants through integrated evidence-based practice ‘programme domains’ and cross cutting disciplinary/sectoral themes
10 to 13 Sep 2024, 09:00-18:30
Prague
View all our news and events

Contact us

Research, Evidence & Development Initiative 
Liverpool School of Tropical Medicine
Pembroke Place
Liverpool
L3 5QA

+44 (0)151 705 3203

Paula [dot] Waugh [at] lstmed [dot] ac [dot] uk

Follow us

  • Facebook
  • Twitter

READ-It (project number 300342-104) is funded by the Foreign, Commonwealth and Development Office (FCDO)

  • Privacy
  • Disclaimer
A Remora website by Manta Ray Media